In the United States, human papillomavirus (HPV) and Papanicolaou (Pap) testing (cotesting) for cervical
screening in women ages 30 to 65 years is the preferred strategy, and cytology alone is acceptable. Recently, a proprietary automated test for identifying high-risk HPV types for primary cervical screening …

Read more >